These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 17251309

  • 1. Effect of mannose chain length on targeting of glucocerebrosidase for enzyme replacement therapy of Gaucher disease.
    Van Patten SM, Hughes H, Huff MR, Piepenhagen PA, Waire J, Qiu H, Ganesa C, Reczek D, Ward PV, Kutzko JP, Edmunds T.
    Glycobiology; 2007 May; 17(5):467-78. PubMed ID: 17251309
    [Abstract] [Full Text] [Related]

  • 2. Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher's disease using a plant cell system.
    Shaaltiel Y, Bartfeld D, Hashmueli S, Baum G, Brill-Almon E, Galili G, Dym O, Boldin-Adamsky SA, Silman I, Sussman JL, Futerman AH, Aviezer D.
    Plant Biotechnol J; 2007 Sep; 5(5):579-90. PubMed ID: 17524049
    [Abstract] [Full Text] [Related]

  • 3. Dexamethasone-mediated up-regulation of the mannose receptor improves the delivery of recombinant glucocerebrosidase to Gaucher macrophages.
    Zhu Y, Li X, Schuchman EH, Desnick RJ, Cheng SH.
    J Pharmacol Exp Ther; 2004 Feb; 308(2):705-11. PubMed ID: 14610228
    [Abstract] [Full Text] [Related]

  • 4. Production of active human glucocerebrosidase in seeds of Arabidopsis thaliana complex-glycan-deficient (cgl) plants.
    He X, Galpin JD, Tropak MB, Mahuran D, Haselhorst T, von Itzstein M, Kolarich D, Packer NH, Miao Y, Jiang L, Grabowski GA, Clarke LA, Kermode AR.
    Glycobiology; 2012 Apr; 22(4):492-503. PubMed ID: 22061999
    [Abstract] [Full Text] [Related]

  • 5. Pichia pastoris-produced mucin-type fusion proteins with multivalent O-glycan substitution as targeting molecules for mannose-specific receptors of the immune system.
    Gustafsson A, Sjöblom M, Strindelius L, Johansson T, Fleckenstein T, Chatzissavidou N, Lindberg L, Angström J, Rova U, Holgersson J.
    Glycobiology; 2011 Aug; 21(8):1071-86. PubMed ID: 21474492
    [Abstract] [Full Text] [Related]

  • 6. Production of recombinant β-glucocerebrosidase in wild-type and glycoengineered transgenic Nicotiana benthamiana root cultures with different N-glycan profiles.
    Uthailak N, Kajiura H, Misaki R, Fujiyama K.
    J Biosci Bioeng; 2022 May; 133(5):481-488. PubMed ID: 35190260
    [Abstract] [Full Text] [Related]

  • 7. A comparison of the pharmacological properties of carbohydrate remodeled recombinant and placental-derived beta-glucocerebrosidase: implications for clinical efficacy in treatment of Gaucher disease.
    Friedman B, Vaddi K, Preston C, Mahon E, Cataldo JR, McPherson JM.
    Blood; 1999 May 01; 93(9):2807-16. PubMed ID: 10216074
    [Abstract] [Full Text] [Related]

  • 8. Delivery of lysosomal enzymes for therapeutic use: glucocerebrosidase as an example.
    Grabowski GA.
    Expert Opin Drug Deliv; 2006 Nov 01; 3(6):771-82. PubMed ID: 17076599
    [Abstract] [Full Text] [Related]

  • 9. Imaging of enzyme replacement therapy using PET.
    Phenix CP, Rempel BP, Colobong K, Doudet DJ, Adam MJ, Clarke LA, Withers SG.
    Proc Natl Acad Sci U S A; 2010 Jun 15; 107(24):10842-7. PubMed ID: 20534487
    [Abstract] [Full Text] [Related]

  • 10. Effect of C2-associated carbohydrate structure on Ig effector function: studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells.
    Wright A, Morrison SL.
    J Immunol; 1998 Apr 01; 160(7):3393-402. PubMed ID: 9531299
    [Abstract] [Full Text] [Related]

  • 11. Binding, internalization, and degradation of mannose-terminated glucocerebrosidase by macrophages.
    Sato Y, Beutler E.
    J Clin Invest; 1993 May 01; 91(5):1909-17. PubMed ID: 8486762
    [Abstract] [Full Text] [Related]

  • 12. Targeted Enzymatic VLP-Nanoreactors with β-Glucocerebrosidase Activity as Potential Enzyme Replacement Therapy for Gaucher's Disease.
    Chauhan K, Olivares-Medina CN, Villagrana-Escareño MV, Juárez-Moreno K, Cadena-Nava RD, Rodríguez-Hernández AG, Vazquez-Duhalt R.
    ChemMedChem; 2022 Oct 06; 17(19):e202200384. PubMed ID: 35918294
    [Abstract] [Full Text] [Related]

  • 13. Production of recombinant human acid β-glucosidase with high mannose-type N-glycans in rice gnt1 mutant for potential treatment of Gaucher disease.
    Jung JW, Choi HY, Huy NX, Park H, Kim HH, Yang MS, Kang SH, Kim DI, Kim NS.
    Protein Expr Purif; 2019 Jun 06; 158():81-88. PubMed ID: 30822514
    [Abstract] [Full Text] [Related]

  • 14. The production of human glucocerebrosidase in glyco-engineered Nicotiana benthamiana plants.
    Limkul J, Iizuka S, Sato Y, Misaki R, Ohashi T, Ohashi T, Fujiyama K.
    Plant Biotechnol J; 2016 Aug 06; 14(8):1682-94. PubMed ID: 26868756
    [Abstract] [Full Text] [Related]

  • 15. Systemic enzyme delivery by blood-brain barrier-penetrating SapC-DOPS nanovesicles for treatment of neuronopathic Gaucher disease.
    Sun Y, Liou B, Chu Z, Fannin V, Blackwood R, Peng Y, Grabowski GA, Davis HW, Qi X.
    EBioMedicine; 2020 May 06; 55():102735. PubMed ID: 32279952
    [Abstract] [Full Text] [Related]

  • 16. High and low affinity carbohydrate ligands revealed for murine SIGN-R1 by carbohydrate array and cell binding approaches, and differing specificities for SIGN-R3 and langerin.
    Galustian C, Park CG, Chai W, Kiso M, Bruening SA, Kang YS, Steinman RM, Feizi T.
    Int Immunol; 2004 Jun 06; 16(6):853-66. PubMed ID: 15136555
    [Abstract] [Full Text] [Related]

  • 17. Biotherapeutic target or sink: analysis of the macrophage mannose receptor tissue distribution in murine models of lysosomal storage diseases.
    Zhang XS, Brondyk W, Lydon JT, Thurberg BL, Piepenhagen PA.
    J Inherit Metab Dis; 2011 Jun 06; 34(3):795-809. PubMed ID: 21416197
    [Abstract] [Full Text] [Related]

  • 18. The Production of Human β-Glucocerebrosidase in Nicotiana benthamiana Root Culture.
    Naphatsamon U, Ohashi T, Misaki R, Fujiyama K.
    Int J Mol Sci; 2018 Jul 06; 19(7):. PubMed ID: 29986415
    [Abstract] [Full Text] [Related]

  • 19. The glycosylation of human serum IgD and IgE and the accessibility of identified oligomannose structures for interaction with mannan-binding lectin.
    Arnold JN, Radcliffe CM, Wormald MR, Royle L, Harvey DJ, Crispin M, Dwek RA, Sim RB, Rudd PM.
    J Immunol; 2004 Dec 01; 173(11):6831-40. PubMed ID: 15557177
    [Abstract] [Full Text] [Related]

  • 20. Transient Expression of Functional Glucocerebrosidase for Treatment of Gaucher's Disease in the Goat Mammary Gland.
    Tavares KC, Dias AC, Lazzarotto CR, Gaudencio Neto S, de Sá Carneiro I, Ongaratto FL, Pinto AF, de Aguiar LH, Calderón CE, Toledo JR, Castro FO, Santos DS, Chies JM, Bertolini M, Bertolini LR.
    Mol Biotechnol; 2016 Jan 01; 58(1):47-55. PubMed ID: 26589705
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.